Decision Layer
What to do with this topic
Use this page to decide whether phase ii detox / clearance belongs near the top of your follow-up list or stays in the background.
What to validate first
Bilirubin, GGT, liver enzyme context
Why this topic matters
Phase II detox / clearance becomes more useful when it is tied to real markers instead of isolated variants.
How to use this page
Use the decision layer first, then move into genes, biomarkers, and related symptom pages only if the topic still looks relevant.
Why It Rises Or Falls
How this topic earns attention
What this topic can explain
Separate conjugation and clearance capacity from generic detox language.
What usually moves it up the list
Phase II detox / clearance rises when GSTP1 and the supporting genes point in a coherent direction, and when the follow-up markers are practical enough to check early.
What usually keeps it in the background
A topic stays lower when the signal depends too heavily on symptoms alone or when other pathways show stronger, more testable drivers.
Validation markers commonly worth checking
Bilirubin
GGT
liver enzyme context
Sample Report View
How Phase II detox / clearance appears in the sample report
GSTP1 is the main reason phase ii detox / clearance rises in the sample report. Additional context comes from GSTT1, CYP1A2, GSTM1.
High follow-up priority
Bilirubin
This topic belongs near the top of the follow-up list because the signal is concentrated and testable.